Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingye Zhao

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
BMC Cancer|March 29, 2026
Optimizing treatment and sequencing strategies for maximal survival and net health benefits in ALK-positive NSCLC: a systematic review and reconstructed individual patient data meta-analysisMingye Zhao, Jiaqi Li, Yunlin Jiang, et al.
JAMA Network Open|May 27, 2025
Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic ReviewMingye Zhao, Taihang Shao, Yue Yin, et al.
Journal of Clinical Epidemiology|July 9, 2026
Externally anchored covariate completion improved target-population effect estimation in meta-analysis with incomplete aggregate data: a simulation studyLingyao Sun, Mingye Zhao, Dachuang Zhou, et al.
Frontiers in Public Health|May 2, 2022
Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-AnalysisMingye Zhao, Xingming Pan, Yue Yin, et al.
Frontiers in Surgery|March 6, 2023
Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysisWei Wang, Zhihao Gong, Mingye Zhao, et al.
BMC Medicine|January 11, 2024
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancerHanqiao Shao, Mingye Zhao, Ai-Jia Guan, et al.
Cost Effectiveness and Resource Allocation : C/E|November 2, 2023
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation methodQian Peng, Yue Yin, Min Liang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 11, 2023
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experimentYue Yin, Qian Peng, Longhao Ma, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
BMC Cancer|March 29, 2026
Optimizing treatment and sequencing strategies for maximal survival and net health benefits in ALK-positive NSCLC: a systematic review and reconstructed individual patient data meta-analysisMingye Zhao, Jiaqi Li, Yunlin Jiang, et al.
JAMA Network Open|May 27, 2025
Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic ReviewMingye Zhao, Taihang Shao, Yue Yin, et al.
Journal of Clinical Epidemiology|July 9, 2026
Externally anchored covariate completion improved target-population effect estimation in meta-analysis with incomplete aggregate data: a simulation studyLingyao Sun, Mingye Zhao, Dachuang Zhou, et al.
Frontiers in Public Health|May 2, 2022
Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-AnalysisMingye Zhao, Xingming Pan, Yue Yin, et al.
Frontiers in Surgery|March 6, 2023
Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysisWei Wang, Zhihao Gong, Mingye Zhao, et al.
BMC Medicine|January 11, 2024
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancerHanqiao Shao, Mingye Zhao, Ai-Jia Guan, et al.
Cost Effectiveness and Resource Allocation : C/E|November 2, 2023
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation methodQian Peng, Yue Yin, Min Liang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 11, 2023
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experimentYue Yin, Qian Peng, Longhao Ma, et al.
Pageof 4